Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 401–425 of 7,816 matching trials · page 17 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Metformin in Alzheimer's Dementia Prevention NCT04098666 Placebo oral tablet; extended release metformin Runs in: United States · 22 sites |
PHASE2|PHASE3 other |
ACTIVE_NOT_RECRUITING | 326 | Columbia University OTHER |
2026-08-11 |
|
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia NCT04251910 Sublingual film containing Dexmedetomidine; Sublingual Placebo Film Runs in: United States · 5 sites |
PHASE1|PHASE2 other |
COMPLETED | 100 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia NCT04268303 Sublingual film containing dexmedetomidine (BXCL501); Placebo Film Runs in: United States · 15 sites |
PHASE3 other |
COMPLETED | 380 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder NCT04276883 Sublingual film containing Dexmedetomidine (BXCL501); Placebo Film Runs in: United States · 15 sites |
PHASE3 other |
COMPLETED | 380 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal NCT04470050 Dexmedetomidine; Placebo Runs in: United States · 3 sites |
PHASE1|PHASE2 other |
COMPLETED | 225 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia NCT04957537 semantic therapy and semantic re-education Runs in: France · 1 site |
NA other |
RECRUITING | 15 | University Hospital, Toulouse OTHER |
2026-08-11 |
|
Interventions in Mathematics and Cognitive Skills NCT05201534 Interventions in Mathematics and Cognitive Skills - Experimental; I... Runs in: United States · 1 site |
NA other |
RECRUITING | 180 | Stanford University OTHER |
2026-08-11 |
|
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II) NCT05271552 BXCL501; Matching Placebo Runs in: United States · 11 sites |
PHASE3 other |
COMPLETED | 151 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia NCT05276830 BXCL501; BXCL501; Placebo film Runs in: United States · 3 sites |
PHASE2 other |
TERMINATED | 5 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients NCT05313386 BXCL501; Placebo film Runs in: United States · 1 site |
PHASE2 other |
WITHDRAWN | 0 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Neuromodulation of Memory in Aging NCT05460468 Transcranial Magnetic Stimulation Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | Indiana University OTHER |
2026-08-11 |
|
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder NCT06041646 Sublingual film containing Igalmi Runs in: United States · 2 sites |
PHASE4 other |
COMPLETED | 29 | BioXcel Therapeutics Inc INDUSTRY |
2026-08-11 |
|
Comprehensive Dementia Management : From Translational Medicine to Innovative Care NCT06214962 (multiple training modalities, MTM) Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 652 | Kaohsiung Medical University Chung-Ho Memorial Hospital OTHER |
2026-08-11 |
|
Compass for Care: A Theory-driven Mobile Solution to Promote Well-being Among Caregivers of Individuals With ADRD NCT06249139 Compass for Care (Well-being intervention); Compass for Care (Safet... Runs in: United States · 1 site |
NA other |
COMPLETED | 278 | Pro-Change Behavior Systems OTHER |
2026-08-11 |
|
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) NCT07116473 Acoramidis (AG10) |
PHASE3 other |
NOT_YET_RECRUITING | 250 | Eidos Therapeutics, a BridgeBio company INDUSTRY |
2026-08-11 |
|
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population NCT07174869 Runs in: United States · 1 site |
NA other |
COMPLETED | 32 | Indivi AG INDUSTRY |
2026-08-11 |
|
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) NCT07204977 Acamprosate calcium Runs in: United States · 1 site |
PHASE1 other |
ACTIVE_NOT_RECRUITING | 30 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2026-08-11 |
|
ALDH2 Genetic Testing in East Asian Community NCT07392775 Genetic Test Results Return; Alcohol Flushing Education Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 100 | Northwestern University OTHER |
2026-08-11 |
|
Lived Experience Narratives in Dementia NCT07757178 Online LEND Intervention Runs in: United Kingdom · 2 sites |
NA other |
RECRUITING | 60 | University of Nottingham OTHER |
2026-08-11 |
|
Safety Assessment of H2 Inhalation in Patients With Mild Cognitive Impairment NCT07757542 Molecular hydrogen inhalation Runs in: Czechia · 1 site |
PHASE2 other |
RECRUITING | 34 | University of Ostrava OTHER |
2026-08-11 |
|
Alzheimer's Disease Research Center (ADRC) PET Component Study NCT07758660 18F-MK6240; 18F-Florbetaben (FBB) Runs in: United States · 1 site |
PHASE2 other |
ENROLLING_BY_INVITATION | 120 | Patrick Lao OTHER |
2026-08-11 |
|
Primary Care Screening and Intervention for Patients With Dementia and Caregivers NCT07758738 SIRENS application; SIRENS screening Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 774 | Weill Medical College of Cornell University OTHER |
2026-08-11 |
|
Multisensory 40-Hz Stimulation for Alzheimer's Disease NCT07758751 Multisensory 40-Hz Stimulation Device; Sham Multisensory Stimulation |
NA other |
NOT_YET_RECRUITING | 60 | Beijing Tiantan Hospital OTHER |
2026-08-11 |
|
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment NCT04558164 Active Theta Burst Stimulation; Sham Theta Burst Stimulation Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 70 | University of California, Los Angeles OTHER |
2026-08-10 |
|
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study NCT05007353 Structured Lifestyle Intervention; Self-Guided Intervention Runs in: Singapore · 3 sites |
NA other |
COMPLETED | 1,212 | National University of Singapore OTHER |
2026-08-10 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial